기본 통계
| CIK | 1792030 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to IM Cannabis Corp
SEC Filings (Chronological Order)
이 페이지는 다른 곳에서 제공하는 소유권 보고서를 제외한 SEC 보고서의 전체 리스트를 시간 순으로 정리한 것입니다.
| June 3, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2026. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| June 3, 2026 |
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing Exhibit 99.1 IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing TORONTO and GLIL YAM, Israel, June 3, 2026 - IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the “Lender”) |
|
| June 3, 2026 |
Exhibit 4.1 CONVERTIBLE PROMISSORY NOTE UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE OCTOBER 3 2026. NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELI |
|
| June 3, 2026 |
Exhibit 10.1 NOTE PURCHASE AGREEMENT THIS NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of June 3, 2026, is by and between IM CANNABIS CORP., a company incorporated under the laws of British Columbia with head offices located at Suite 3606 – 833 Seymour Street, Vancouver, British Columbia, V6B 0G4 (the “Company”), and L.I.A. Pure Capital Ltd. (the “Investor”). WITNESSETH WHEREAS, the Compan |
|
| June 3, 2026 |
COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 4.2 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE OCTOBER 3, 2026. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE |
|
| May 13, 2026 |
IM Cannabis Corp. Announces First Quarter 2026 Financial Results Exhibit 99.1 IM Cannabis Corp. Announces First Quarter 2026 Financial Results TORONTO and GLIL YAM, Israel, May 13, 2026 /PRNewswire/ - IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced its financial results for the first quarter ended March 31, 2026. All amounts were reported in Canadian dollars, unless oth |
|
| May 13, 2026 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Asi Levi, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended March 31, 2026. 2. No misrepresentations: Based on my knowledge, |
|
| May 13, 2026 |
Exhibit 99.2 IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of March 31, 2026 Canadian dollars in thousands (Unaudited) INDEX Page Notice to Shareholders 2 Interim Condensed Consolidated Statements of Financial Position 3 - 4 Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income 5 - 6 Interim Condensed Consolidated Statements of Change |
|
| May 13, 2026 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended March 31, 2026. 2. No misrepresentations: Based on my knowled |
|
| May 13, 2026 |
Exhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS INTRODUCTION 3 NON-IFRS FINANCIAL MEASURES 4 NOTE REGARDING THE COMPANY’S ACCOUNTING PRACTICES 4 EXECUTIVE SUMMARY 4 RESULTS – Q1 2026 REVENUE 7 STRATEGY IN DETAIL: 8 CORPORATE HIGHLIGHTS AND EVENTS 12 REVENUES AND GROSS MARGINS 16 EXPENSES 17 LIQUIDITY AND CAPITAL RESOURCES 20 SHARE CAPITAL 26 OPERATING, FINANCING AND INVESTING A |
|
| May 13, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2026 (Report No. 2) Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of pri |
|
| May 7, 2026 |
Exhibit 10.1 NOTE PURCHASE AGREEMENT THIS NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of May 7, 2026, is by and between IM CANNABIS CORP., a company incorporated under the laws of British Columbia with head offices located at Suite 3606 – 833 Seymour Street, Vancouver, British Columbia, V6B 0G4 (the “Company”), and L.I.A. Pure Capital Ltd. (the “Investor”). WITNESSETH WHEREAS, the Company |
|
| May 7, 2026 |
COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 4.2 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE SEPTEMBER 8, 2026. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (TH |
|
| May 7, 2026 |
Exhibit 4.1 CONVERTIBLE PROMISSORY NOTE UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE SEPTEMBER 8 2026. NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RE |
|
| May 7, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2026. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 7, 2026 |
IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings Exhibit 99.1 IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings TORONTO and GLIL YAM, Israel, May 7, 2026 - IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$300,000 convertible note financing in a private placement with an institutional investor, bringing the |
|
| April 10, 2026 |
IMC Announces Receipt of Nasdaq Minimum Bid Price Notification Exhibit 99.1 IMC Announces Receipt of Nasdaq Minimum Bid Price Notification TORONTO and GLIL YAM, Israel, April 10, 2026 – /PRNewswire/ - IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced that it has received a written notice (the “Notice”) from Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company |
|
| April 10, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of: April 2026 (Report No. 2). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of |
|
| April 6, 2026 |
Exhibit 4.1 CONVERTIBLE PROMISSORY NOTE UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE AUGUST 6 2026. NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIA |
|
| April 6, 2026 |
Eexhibit 10.1 NOTE PURCHASE AGREEMENT THIS NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of April 5, 2026, is by and between IM CANNABIS CORP., a company incorporated under the laws of British Columbia with head offices located at Suite 3606 – 833 Seymour Street, Vancouver, British Columbia, V6B 0G4 (the “Company”), and L.I.A. Pure Capital Ltd. (the “Investor”). WITNESSETH WHEREAS, the Comp |
|
| April 6, 2026 |
COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 4.2 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE AUGUST 7, 2026. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ |
|
| April 6, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2026. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| March 31, 2026 |
Exhibit 99.1 IM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash Flow TORONTO and GLIL YAM, Israel, March XX, 2026 /PRNewswire/ - IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today reported its audited consolidated financial results as of and for the |
|
| March 31, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 (Report No. 2) Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4 ( |
|
| March 30, 2026 |
CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a) or 15d-14(a) Exhibit 12.1 CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a) or 15d-14(a) I, Oren Shuster, certify that: 1. I have reviewed this annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances unde |
|
| March 30, 2026 |
CERTIFICATION PURSUANT TO 18 U.S.C. Section 1350 Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. Section 1350 In connection with the Annual Report of IM Cannabis Corp. (the "Company") on Form 20-F for the period ended December 31, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Oren Shuster, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Sectio |
|
| March 30, 2026 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.2 Fahn Kanne & Co. Head Office 32 Hamasger Street Tel-Aviv 6721118, ISRAEL PO Box 36172, 6136101 T +972 3 7106666 F +972 3 7106660 www.gtfk.co.il CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our report dated March 30, 2026, with respect to the consolidated financial statements included in the Annual Report of IM Cannabis Corp. on Form 20-F for the year ended D |
|
| March 30, 2026 |
CERTIFICATION PURSUANT TO 18 U.S.C. Section 1350 Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. Section 1350 In connection with the Annual Report of IM Cannabis Corp. (the "Company") on Form 20-F for the period ended December 31, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Asi Levi, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 90 |
|
| March 30, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT |
|
| March 30, 2026 |
CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a) or 15d-14(a) Exhibit 12.2 CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a) or 15d-14(a) I, Asi Levi, certify that: 1. I have reviewed this annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under wh |
|
| March 30, 2026 |
IM CANNABIS CORP. INSIDER TRADING POLICY March 30, 2026 IM CANNABIS CORP. INSIDER TRADING POLICY Exhibit 11.1 IM CANNABIS CORP. INSIDER TRADING POLICY Date: March 30, 2026 IM CANNABIS CORP. INSIDER TRADING POLICY 1. Purpose of this Policy The board of directors (the “Board”) of IM Cannabis Corp. (the “Company”) has adopted this Insider Trading Policy (this “Policy”), which is designed to provide guidance to directors, officers, employees, consultants, contractors, agents and other related per |
|
| March 30, 2026 |
For the Year Ended December 31, Exhibit 15.4 Item 5. Operating and Financial Review and Prospects A. Operating Results The following discussion and analysis of IM Cannabis Corp.’s (the “Company”) results of operations and financial condition should be read in conjunction with the Company’s consolidated financial statements and the related notes included elsewhere in the Annual Report on Form 20-F for the year ended December 31, |
|
| March 30, 2026 |
Consent of Independent Registered Public Accounting Firm Exhibit 15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form F-10 No. 333-254255) and Registration Statements (Form F-3 Nos. 333-288346, 333-289571 and 333-293236) of IM Cannabis Corp. and in the related prospectuses of our report dated March 30, 2026, with respect to the consolidated financial statements of |
|
| March 17, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4 (Address of prin |
|
| March 17, 2026 |
Exhibit 99.1 IMC Announces a Strategic Entry to the Cyber Drone Interception and Satellite Intelligence Markets by Signing a Non-Binding Agreement to Acquire 51% of Blackaxe Technologies TORONTO and GLIL YAM, Israel, March. 17, 2026 /PRNewswire/ - IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced that, follo |
|
| February 5, 2026 |
As filed with the Securities and Exchange Commission on February 5, 2026 As filed with the Securities and Exchange Commission on February 5, 2026 Registration No. |
|
| February 5, 2026 |
AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTE Exhibit 4.5 AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTE This Amendment No. 1 (this “Amendment”) to that certain Convertible Promissory Note, issued January 21, 2026 (the “Note”), by IM Cannabis Corp., a company incorporated under the laws of British Columbia (the “Company”), issued to L.I.A. Pure Capital Ltd. (the “Holder”), is entered into as of February 5, 2026. Capitalized terms used but not |
|
| February 5, 2026 |
Ex-Filing Fees CALCULATION OF FILING FEE TABLES F-3 IM Cannabis Corp Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Common Shares, no par value per share (1) Other 9,788,966 $ 1. |
|
| February 5, 2026 |
AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTE Exhibit 4.6 AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTE This Amendment No. 1 (this “Amendment”) to that certain Convertible Promissory Note, issued January 21, 2026 (the “Note”), by IM Cannabis Corp., a company incorporated under the laws of British Columbia (the “Company”), issued to L.I.A. Pure Capital Ltd. (the “Holder”), is entered into as of February 5, 2026. Capitalized terms used but not |
|
| January 26, 2026 |
Exhibit 10.1 NOTE PURCHASE AGREEMENT THIS NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of January 7, 2026, is by and between IM CANNABIS CORP., a company incorporated under the laws of British Columbia with head offices located at Suite 3606 – 833 Seymour Street, Vancouver, British Columbia, V6B 0G4 (the “Company”), and L.I.A. Pure Capital Ltd. (the “Investor”). WITNESSETH WHEREAS, the Com |
|
| January 26, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2026 (Report No. 2). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address o |
|
| January 26, 2026 |
COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 4.4 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE MAY 22, 2026. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U. |
|
| January 26, 2026 |
IM Cannabis Raises US$2,171,660.40 in Note Purchase Agreements Exhibit 99.1 IM Cannabis Raises US$2,171,660.40 in Note Purchase Agreements TORONTO and GLIL YAM, Israel, January 26, 2026 - IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced that it has raised a total of US$2,171,660.40 in debt financings from an arm’s length third party (the “Lender”) in order to m |
|
| January 26, 2026 |
Exhibit 4.2 CONVERTIBLE PROMISSORY NOTE UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE May 22, 2026. NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIAN |
|
| January 26, 2026 |
Exhibit 10.2 NOTE PURCHASE AGREEMENT THIS NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of January 21, 2026, is by and between IM CANNABIS CORP., a company incorporated under the laws of British Columbia with head offices located at Suite 3606 – 833 Seymour Street, Vancouver, British Columbia, V6B 0G4 (the “Company”), and L.I.A. Pure Capital Ltd. (the “Investor”). WITNESSETH WHEREAS, the Co |
|
| January 26, 2026 |
COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 4.3 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE MAY 22, 2026. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U. |
|
| January 26, 2026 |
Exhibit 4.1 CONVERTIBLE PROMISSORY NOTE UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE May 8, 2026. NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIANC |
|
| January 5, 2026 |
IM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of Directors Exhibit 99.1 IM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of Directors TORONTO and GLIL YAM, Israel, January 5, 2026 - IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), medical cannabis company with operations in Israel and Germany, announced today that Mr. Alon Dayan has been appointed to the Company's board of directors effective December 31, 2025. Mr. Dayan, who |
|
| January 5, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2026 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| December 30, 2025 |
Exhibit 99.1 IM Cannabis Explores U.S. Market Entry Following President Trump's Executive Order on Increasing Medical Marijuana and Cannabidiol Research Engages Exclusive Financial Advisors for U.S. Opportunities and Potential Divestitures of German and Israeli Operations; TORONTO and GLIL YAM, Israel, December 30, 2025 - IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), medical cannabis |
|
| December 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 (Report No. 2) Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address o |
|
| December 12, 2025 |
IM Cannabis Appoints Asi Levi as Chief Financial Officer Exhibit 99.1 IM Cannabis Appoints Asi Levi as Chief Financial Officer TORONTO and GLIL YAM, Israel, December 12, 2025 - IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced, further to its press release dated October 29, 2025, the appointment of Asi Levi, CPA, as the Company’s Chief Financial Officer (“ |
|
| December 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| November 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 (Report No. 3). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address |
|
| November 17, 2025 |
Exihibit 99.1 November 14, 2025 510 Burrard Street, 3rd Floor Vancouver BC, V6C 3B9 www.computershare.com To: All Canadian Securities Regulatory Authorities CANCELLATION NOTICE Subject: IM CANNABIS CORP. Dear Sir/Madam: We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: Meeting Type : Special Meeting - Cancelled Record Date for Notice of Mee |
|
| November 13, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Uri Birenberg, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “Interim Filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended September 30, 2025. 2. No misrepresentations: Based on my kn |
|
| November 13, 2025 |
Exhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 7 GEOGRAPHIES AND NEW MARKETS 7 BRANDS 9 NEW PRODUCT OFFERINGS 11 HIGH-QUALITY, RELIABLE SUPPLY 11 CORPORATE HIGHLIGHTS AND EVENTS 12 REVIEW OF FINANCIAL PERFORMANCE 17 LEGAL AND REGULATORY 55 RISK FACTORS 66 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 73 2 Management’s Discussion an |
|
| November 13, 2025 |
Exhibit 99.1 IM Cannabis Reports Third Quarter 2025 Financial Results TORONTO and GLIL YAM, Israel, November 13, 2025 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the third quarter and nine months ended September 30, 2025. All amounts are reported in Canadian dollars and compared to th |
|
| November 13, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended September 30, 2025. 2. No misrepresentations: Based on my k |
|
| November 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 (Report No. 2). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address |
|
| November 13, 2025 |
Exhibit 99.2 IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of September 30, 2025 Canadian dollars in thousands (Unaudited) INDEX Page Interim Condensed Consolidated Statements of Financial Position F-2 - F-3 Interim Condensed Consolidated Statements of Operations and Other Comprehensive Loss F-4 - F-5 Interim Condensed Consolidated Statements of Changes in Shareholders' |
|
| November 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 (Report No. 1). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address |
|
| November 6, 2025 |
IM Cannabis to Report third Quarter 2025 Financial Results on Thursday, November 13 Exhibit 99.1 IM Cannabis to Report third Quarter 2025 Financial Results on Thursday, November 13th at 9:00am ET TORONTO and GLIL YAM, Israel, November 6, 2025/CNW/ - IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third quarter 2025 ended Septemb |
|
| October 29, 2025 |
Exhibit 99.1 October 28, 2025 510 Burrard Street, 3rd Floor Vancouver BC, V6C 3B9 www.computershare.com To: All Canadian Securities Regulatory Authorities Subject: IM CANNABIS CORP. Dear Sir/Madam: We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: Meeting Type : Special Meeting Record Date for Notice of Meeting : November 12, 2025 Record Da |
|
| October 29, 2025 |
IM Cannabis Announces CFO Departure Exhibit 99.1 IM Cannabis Announces CFO Departure Toronto, Ontario and GLIL YAM, Israel, October 29, 2025/CNW/ - IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading international medical cannabis company with operations in Israel and Germany, today announced that Uri Birenberg, the Company's Chief Financial Officer, will be stepping down from his role for personal r |
|
| October 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 (Report No. 2). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address o |
|
| October 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 (Report No. 3). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address o |
|
| October 23, 2025 |
Exhibit 99.1 IM Cannabis Signs Non-Binding Term Sheet to Acquire 60% Stake in Innovative Quantum Computing Bio Data Company for Up to $54 Million TORONTO and GLIL YAM, Israel, October 23, 2025 - IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced the signing of a non-binding indicative term sheet for a |
|
| October 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| September 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 (Report No. 2). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address |
|
| September 16, 2025 |
Exhibit 99.1 IM Cannabis Announces Board Changes and Strategic Decision to Identify Additional Business Opportunities TORONTO and GLIL YAM, Israel, September 16, 2025 - IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced the following changes to its Board of Directors (the “Board”). Effective September |
|
| September 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4 (Address of |
|
| September 5, 2025 |
IM Cannabis Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement Exhibit 99.1 IM Cannabis Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement TORONTO and GLIL YAM, Israel, September 5, 2025/CNW/ - IM Cannabis Corp. (NASDAQ: IMCC) (the “Company”, “IM Cannabis”, or “IMC”), a leading medical cannabis company with operations in Israel and Germany, today announced that it received notice from Nasdaq on September 4, 2025 that the Company has regai |
|
| August 27, 2025 |
X0101 EFFECT 33 LIVE 2025-08-27 09:15:00 F-3 0001792030 IM Cannabis Corp. 333-289571 |
|
| August 25, 2025 |
IM CANNABIS CORP. Kibbutz Glil Yam, Central District Israel 4690500 IM CANNABIS CORP. Kibbutz Glil Yam, Central District Israel 4690500 August 25, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: IM Cannabis Corp. (CIK 0001792030) Registration Statement on Form F-3 (File No. 333-289571) (the “Registration Statement”) Request for Accelerat |
|
| August 25, 2025 |
As filed with the Securities and Exchange Commission on August 25, 2025 As filed with the Securities and Exchange Commission on August 25, 2025 Registration No. |
|
| August 20, 2025 |
August 20, 2025 Oren Shuster Chief Executive Officer IM Cannabis Corp. 3606-833 Seymour Street Vancouver, BC, V6B 0G4, Canada Re: IM Cannabis Corp. Registration Statement on Form F-3 Filed August 13, 2025 File No. 333-289571 Dear Oren Shuster: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for ac |
|
| August 13, 2025 |
COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 4.4 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE MARCH 13, 2025. THE WARRANTS EVIDENCED HEREBY ARE EXERCISABLE AT OR BEFORE 4:00 P.M. (TORONTO TIME) ON NOVEMBER 12, 2026, AFTER WHICH TIME THE WARRANTS EVIDENCED HEREBY SHALL BE DEEMED TO BE V |
|
| August 13, 2025 |
As filed with the Securities and Exchange Commission on August 13, 2025 As filed with the Securities and Exchange Commission on August 13, 2025 Registration No. |
|
| August 13, 2025 |
IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing Exhibit 99.3 IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing Toronto, Ontario and Glil Yam, Israel – August 13, 2025 – IM Cannabis Corp. (“IM Cannabis” or the “Company”) (NASDAQ: IMCC), a leading medical cannabis company with operations in Israel and Germany, announces that it has agreed with holders (each, a “Holder”) of common share purchase warrants (“ |
|
| August 13, 2025 |
Calculation of Filing Fee Tables F-3 IM Cannabis Corp. Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial E |
|
| August 13, 2025 |
COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 4.1 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE DECEMBER 1, 2025. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE |
|
| August 13, 2025 |
AMENDMENT NO. 1 TO COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 4.5 AMENDMENT NO. 1 TO COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. This Amendment No. 1 to the Common Share Purchase Warrant (this “Amendment”) dated this [] day of August 2025, by and among IM Cannabis Corp., a British Columbia corporation (the “Company”) and [] (the “Holder”). WHEREAS, the Holder holds outstanding warrants to purchase up to (i) [] common shares, no par value per shar |
|
| August 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 (Report No. 3). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of |
|
| August 12, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Uri Birenberg, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “Interim Filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended June 30, 2025. 2. No misrepresentations: Based on my knowled |
|
| August 12, 2025 |
Exhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 7 GEOGRAPHIES AND NEW MARKETS 7 BRANDS 8 NEW PRODUCT OFFERINGS 10 HIGH-QUALITY, RELIABLE SUPPLY 10 CORPORATE HIGHLIGHTS AND EVENTS 11 REVIEW OF FINANCIAL PERFORMANCE 19 LEGAL AND REGULATORY 58 RISK FACTORS 67 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 75 2 Management’s Discussion an |
|
| August 12, 2025 |
IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2025 Exhibit 99.2 IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2025 (Unaudited) IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2025 Canadian dollars in thousands (Unaudited) INDEX Page Interim Condensed Consolidated Statements of Financial Position F-2 - F-3 Interim Condensed Consolidated Statements of Operations and Other Co |
|
| August 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| August 12, 2025 |
IM Cannabis Reports Second Quarter 2025 Financial Results Exhibit 99.1 IM Cannabis Reports Second Quarter 2025 Financial Results IMC Delivers Strong Profit and Margin Growth Despite Revenue Impact from External Challenges in Q2 2025 TORONTO and GLIL YAM, Israel, August 12, 2025 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the second quarter e |
|
| August 12, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended June 30, 2025. 2. No misrepresentations: Based on my knowle |
|
| August 4, 2025 |
IM Cannabis to Report Second Quarter 2025 Financial Results on Tuesday, August 12th at 9:00am ET Exhibit 99.1 IM Cannabis to Report Second Quarter 2025 Financial Results on Tuesday, August 12th at 9:00am ET TORONTO and GLIL YAM, Israel, August 4, 2025/CNW/ - IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter 2025 ended June 30, 2 |
|
| August 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| July 31, 2025 |
COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 99.6 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE , 2025. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SE |
|
| July 31, 2025 |
Exhibit 99.5 ADVISORY AGREEMENT This Consulting Agreement (the “Agreement”) is entered into and made effective as of the 31 day of July, 2025, BY AND BETWEEN: Pure Equity Ltd., a private company duly incorporated under the laws of the State of Israel, having its registered office at 20 Raul Wallenberg Street, Ramat Hachayal, Tel Aviv, Israel, Company No. 516006418 (hereinafter referred to as the “ |
|
| July 31, 2025 |
IM CANNABIS CORP. Subscription Agreement for Units Exhibit 99.1 CANADA/UNITED STATES/OFFSHORE THE SECURITIES BEING SUBSCRIBED FOR HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”), OR UNDER ANY OTHER APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS DEFINED HEREIN) UNLESS SUCH SECURITIES ARE REGISTERE |
|
| July 31, 2025 |
COMMON SHARE PURCHASE WARRANT IM CANNABIS CORP. Exhibit 99.3 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE DECEMBER 1, 2025. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (TH |
|
| July 31, 2025 |
IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million Exhibit 99.7 IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million Toronto, Ontario and Glil Yam, Israel – July 31, 2025 – IM Cannabis Corp. (“IM Cannabis” or the “Company”) (NASDAQ: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, effective July 30, 2025 (the “Closing Date”) it has closed a private plac |
|
| July 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 (Report No. 4). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of p |
|
| July 31, 2025 |
IM CANNABIS CORP. Subscription Agreement for Units Exhibit 99.2 CANADA/UNITED STATES/OFFSHORE THE SECURITIES BEING SUBSCRIBED FOR HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”), OR UNDER ANY OTHER APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS DEFINED HEREIN) UNLESS SUCH SECURITIES ARE REGISTERE |
|
| July 31, 2025 |
PRE-FUNDED COMMON SHARE PURCHASE WARRANT Exhibit 99.4 UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF BEFORE DECEMBER 1, 2025. THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (TH |
|
| July 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 (Report No. 3). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of p |
|
| July 11, 2025 |
IM CANNABIS ANNOUNCES FILING OF SHELF REGISTRATION STATEMENT ON FORM F-3 Exhibit 99.1 IM CANNABIS ANNOUNCES FILING OF SHELF REGISTRATION STATEMENT ON FORM F-3 TORONTO and GLIL YAM, Israel, July 11, 2025 - IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce the filing and effectiveness of a shelf registration statement (the “Shelf Registration”) on Form F-3 with the S |
|
| July 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 (Report No. 2). Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of p |
|
| July 9, 2025 |
Exhibit 99.1 IM Cannabis Announces the Signing of a Loan Agreement and Appointment of Oz Adler to Board of Directors TORONTO and GLIL YAM, Israel, July 9, 2025 - IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Mr. Oz Adler has been appointed to the Company’s board of directors (the “Boa |
|
| July 9, 2025 |
Exhibit 10.1 Loan Agreement Made and signed on the 6 day of July, 2025 BETWEEN: L.I.A. PURE CAPITAL LTD Company Number: 514408715 (Hereinafter each referred to as a 'Lender', and collectively, the 'Lenders') - On the one part - AND: IM Cannabis Corp. Company Number: 205955 (Hereinafter referred to as the 'Borrower' and/or the 'Company') - On the other part - Whereas the Borrower is a public compan |
|
| July 7, 2025 |
IM Cannabis Corp. Beit Hakshatot, Kibutz Glil-Yam 4690500, Israel IM Cannabis Corp. Beit Hakshatot, Kibutz Glil-Yam 4690500, Israel July 7, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 RE: IM Cannabis Corp. (CIK: 0001792030) Registration Statement No. 333-288346 on Form F-3 (the “Registration Statement”) Request for Acceleration of Effect |
|
| July 2, 2025 |
July 2, 2025 Oren Shuster Chief Executive Officer and Chairman of the Board IM Cannabis Corp. |
|
| July 1, 2025 |
IM Cannabis Provides Corporate Updates Exhibit 99.1 IM Cannabis Provides Corporate Updates TORONTO and GLIL YAM, Israel, July 1, 2025/CNW/ - IM Cannabis Corp. (NASDAQ: IMCC) (the “Company”, “IM Cannabis”, or “IMC”), a leading medical cannabis company with operations in Israel and Germany, today announced the following corproate updates. As previously reported on April 11, 2025, the Company received a deficiency letter (the “Nasdaq Lett |
|
| July 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4 (Address of princ |
|
| June 26, 2025 |
Exhibit 107 Calculation of Filing Fee Tables FORM F-3 (Form Type) IM CANNABIS CORP. |
|
| June 26, 2025 |
As filed with the Securities and Exchange Commission on June 26, 2025 As filed with the Securities and Exchange Commission on June 26, 2025 Registration No. |
|
| May 28, 2025 |
IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange Exhibit 99.1 IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange TORONTO and GLIL YAM, Israel, May 28, 2025 /CNW/ - IM Cannabis Corp. (the “Company” or “IMC”) (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announces that it has applied for a voluntary delisting of its common shares (“Shares”) from the Canadian Securities Exchange (the “CS |
|
| May 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 27, 2025 |
DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Exhibit 99.1 THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES IM Cannabis Provides Corporate Updates Toronto, Ontario and Glil Yam, Israel – May 27, 2025 – IM Cannabis Corp. (“IM Cannabis” or the “Company”) (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with op |
|
| May 15, 2025 |
Eexhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 5 STRATEGY IN DETAIL 7 GEOGRAPHIES AND NEW MARKETS 7 BRANDS 8 NEW PRODUCT OFFERINGS 10 HIGH-QUALITY, RELIABLE SUPPLY 10 CORPORATE HIGHLIGHTS AND EVENTS 11 REVIEW OF FINANCIAL PERFORMANCE 17 LEGAL AND REGULATORY 52 RISK FACTORS 62 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 69 2 Management’s Discussion a |
|
| May 15, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Uri Birenberg, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended March 31, 2025. 2. No misrepresentations: Based on my knowle |
|
| May 15, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended March 31, 2025. 2. No misrepresentations: Based on my knowl |
|
| May 15, 2025 |
Exhibit 99.2 IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of March 31, 2025 Canadian dollars in thousands (Unaudited) INDEX Page Interim Condensed Consolidated Statements of Financial Position 2 - 3 Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income 4 - 5 Interim Condensed Consolidated Statements of Changes in Equity 6 Interim Con |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 15, 2025 |
Exhibit 99.1 IM CANNABIS CORP. IM Cannabis Reports First Quarter Financial Results IMC Delivers Net Profit and 87% Gross Margin Improvement in Q1, Reflecting Strategic and Operational Progress. TORONTO, and GLIL YAM, Israel, May 15, 2025 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results t |
|
| May 7, 2025 |
Exhibit 99.1 IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction TORONTO and GLIL YAM, Israel, May 7, 2025/CNW/ - IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) (the “Company” or “IM Cannabis”), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executiv |
|
| May 6, 2025 |
IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15 Exhibit 99.1 IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET TORONTO and GLIL YAM, Israel, May 6, 2025 - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2025 ended March 31, |
|
| May 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| May 5, 2025 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 04/30/2025: 3,085,452 Common Shares. Date: May 5, 2025 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Wher |
|
| April 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4 (Address of prin |
|
| April 11, 2025 |
IM Cannabis Provides Corporate Updates Exhibit 99.1 IM Cannabis Provides Corporate Updates TORONTO and GLIL YAM, Israel, April 11, 2025/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company”, “IM Cannabis”, or “IMC”), a leading medical cannabis company with operations in Israel and Germany, today announced the following corproate updates. Nasdaq Notification Letter The Company has received a written notification (the “Notif |
|
| April 3, 2025 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 03/31/2025: 3,085,452 Common Shares. Date: April 3, 2025 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Wh |
|
| April 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| March 31, 2025 |
IM CANNABIS CORP. INCENTIVE COMPENSATION RECOVERY POLICY Exhibit 97 IM CANNABIS CORP. INCENTIVE COMPENSATION RECOVERY POLICY 1. Introduction. The Board of Directors of IM Cannabis Corp. (the “Company”) believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company's compensation philosophy. The Board has therefore adopted this pol |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| March 31, 2025 |
DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT Exhibit 2.1 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT Except as otherwise stated, the information in this Description of Securities is provided as of the date of the Annual Report. The following summary does not purport to be complete. The summary is subject to and qualified by the Articles of IM Cannabis Corp. (“Articles”), which are filed as Exhibit 1.1 to the Ann |
|
| March 31, 2025 |
Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of IM Cannabis Corp. (the "Company") on Form 20-F for the period ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Uri Birenberg, Chief Financial Officer of the Company, cer |
|
| March 31, 2025 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of IM Cannabis Corp. (the "Company") on Form 20-F for the period ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Oren Shuster, Chief Executive Officer of the Company, cert |
|
| March 31, 2025 |
Exhibit 4.7 Unofficial Translation Loan Agreement and Principles Agreement Executed and Signed on November 29, 2022, in Galil Yam Between: IMC Holdings Ltd. Company No. 515778348 From Beit HaKeshet, Kibbutz Galil Yam, Israel (hereinafter: "the Lender"), On the first part; And: Telecanna Ltd. Company No. 516591781 From 24 A-Sultani Road, Tira, Israel (hereinafter: "the Borrower" or "the Company", a |
|
| March 31, 2025 |
Exhibit 15.4 TABLE OF CONTENTS EXECUTIVE SUMMARY 5 STRATEGY IN DETAIL 7 GEOGRAPHIES AND NEW MARKETS 7 BRANDS 8 NEW PRODUCT OFFERINGS 10 HIGH-QUALITY, RELIABLE SUPPLY 10 CORPORATE HIGHLIGHTS AND EVENTS 11 REVIEW OF FINANCIAL PERFORMANCE 19 LEGAL AND REGULATORY 58 RISK FACTORS 68 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 74 2 Management’s Discussion and Analysis INTRODUCTION IM Cannabis C |
|
| March 31, 2025 |
CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 12.1 CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 I, Oren Shuster, certify that: 1. I have reviewed this annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the ci |
|
| March 31, 2025 |
Re: Cancellation of License Agreement Dated April 2, 2019 Exhibit 4.2 February 26, 2024 To: Focus Medical Herbs Ltd. Beit Hakshatot, Glil Yam, Israel Re: Cancellation of License Agreement Dated April 2, 2019 This letter serves as formal notification that IMC Holdings Ltd. has ceased charging Focus Medical Herbs Ltd. for royalties as of February 26, 2024. Accordingly, we hereby cancel the License Agreement dated April 2, 2019, between IMC Holdings Ltd. an |
|
| March 31, 2025 |
Consent of Independent Registered Public Accounting Firm Exhibit 15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form F-10 No. 333-254255) of IM Cannabis Corp. and in the related Prospectus of our report dated March 28, 2024, with respect to the consolidated financial statements of IM Cannabis Corp. included in this Annual Report (Form 20-F) for the year ended Dece |
|
| March 31, 2025 |
Exhibit 4.8 Unofficial Translation Loan Agreement and Principles Agreement Executed and Signed on January 5, 2025 Between: IMC Holdings Ltd. Company No. 515778348 From Beit HaKeshet, Kibbutz Galil Yam, Israel (hereinafter: "the Lender"), On the first part; And: Nidal Almaghrabi, ID No. 021922893 (hereinafter: "the Purchaser") On the second part; (IMC and the Purchaser shall hereinafter be referred |
|
| March 31, 2025 |
IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results Exhibit 99.1 IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results Q4 2024 Caps a Year of Strategic and Operational Improvements for IMC with 25% Revenue Growth, 42% decrease in Operating Expenses, and $0.5M Adjusted EBITDA Profit. TORONTO, Ontario and GLIL YAM, Israel, March 31, 2025 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an interna |
|
| March 31, 2025 |
CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 12.2 CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 I, Uri Birenberg, certify that: 1. I have reviewed this annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the c |
|
| March 31, 2025 |
Consent of Independent Registered Public Accounting Firm Exhibit 15.2 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form F-10 No. 333-254255) of IM Cannabis Corp. and in the related Prospectus of our report dated March 31, 2025, with respect to the consolidated financial statements of IM Cannabis Corp. included in this Annual Report (Form 20-F) for the year ended Dece |
|
| March 31, 2025 |
Exhibit 4.6 AGREEMENT THIS AGREEMENT (the “Agreement”) is entered into as of the 26 day of May 2024 (the “Effective Date”), by and among IM Cannabis Corp (“Company” or “IMCC”), I.M.C Holdings Ltd. (“Holding Company”), and Kadimastem Ltd. (“Kadimastem”) (each of the parties above – a “Party” and, collectively, the “Parties”). WHEREAS, on February 13, 2024, the Kadimastem and Company entered into a |
|
| March 31, 2025 |
Exhibit 15.3 March 31, 2025 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read Item 16F of the Annual Report on Form 20-F dated March 31 , 2025 of IM Cannabis Corp. and are in agreement with the statements contained in the first to fifth paragraphs in Item 16F therein. We have no basis to agree or disagree with other statements of the registrant |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT |
|
| March 31, 2025 |
IM CANNABIS CORP. STOCK TRADING POLICY Exhibit 11.1 IM CANNABIS CORP. STOCK TRADING POLICY IM CANNABIS CORP. STOCK TRADING POLICY 1. Purpose of this Policy The board of directors (the “Board”) of IM Cannabis Corp. (the “Company”) has adopted this Stock Trading Policy (the “Policy”), which is designed to provide guidance to the directors, officers and employees of the Company and its subsidiaries (who are referred to collectively in thi |
|
| March 20, 2025 |
Exhibit 99.1 IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET TORONTO and GLIL YAM, Israel, March 20, 2025/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth qu |
|
| March 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| March 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| March 5, 2025 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 02/28/2025: 3,085,452 Common Shares Date: March 5, 2025 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Whe |
|
| February 5, 2025 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 01/31/2025: 3,085,452 Common Shares Date: February 5, 2025 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. |
|
| February 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| January 17, 2025 |
IM CANNABIS CORP. NOTICE OF CHANGE OF AUDITOR Exhibit 99.2 IM CANNABIS CORP. NOTICE OF CHANGE OF AUDITOR To: Fahn Kanne & Co. Grant Thornton Israel And To: Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global And To: Canadian Securities Exchange British Columbia Securities Commission Alberta Securities Commission Ontario Securities Commission Financial And Consumer Services Commission (New Brunswick) Manitoba Securities Commission N |
|
| January 17, 2025 |
Exhibit 99.3 January 16, 2025 Fahn Kanne & Co. Head Office 32 Hamasger Street Tel-Aviv 6721118, ISRAEL PO Box 36172, 6136101 T +972 3 7106666 F +972 3 7106660 www.gtfk.co.il To: Canadian Securities Exchange British Columbia Securities Commission Alberta Securities Commission Ontario Securities Commission Financial And Consumer Services Commission (New Brunswick) Manitoba Securities Commission Nova |
|
| January 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| January 17, 2025 |
IM Cannabis Announces Change of Auditors Exhibit 99.1 IM Cannabis Announces Change of Auditors TORONTO and GLIL YAM, Israel, January 17, 2025 - IM Cannabis Corp. (“IMC” or the “Company”) (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, announces that it has changed its auditor from Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global (the “Predecessor Auditor”) to Fahn Kanne |
|
| January 17, 2025 |
Exhibit 99.4 Kost Forer Gabbay & Kasierer 144 Menachem Begin Road, Building A Tel-Aviv 6492102, Israel Tel: +972-3-6232525 Fax: +972-3-5622555 ey.com January 17, 2025 Canadian Securities Exchange British Columbia Securities Commission Alberta Securities Commission Ontario Securities Commission Financial And Consumer Services Commission (New Brunswick) Manitoba Securities Commission Nova Scotia Sec |
|
| January 6, 2025 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 12/31/2024: 3,085,452 Common Shares Date: January 6, 2025 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. W |
|
| January 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| December 4, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 11/30/2024: 3,085,452 Common Shares Date: December 4, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. |
|
| December 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| November 14, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Uri Birenberg, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended September 30, 2024. 2. No misrepresentations: Based on my kn |
|
| November 14, 2024 |
Exhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 6 GEOGRAPHIES AND NEW MARKETS 6 BRANDS 7 NEW PRODUCT OFFERINGS 11 HIGH-QUALITY, RELIABLE SUPPLY 12 CORPORATE HIGHLIGHTS AND EVENTS 12 REVIEW OF FINANCIAL PERFORMANCE 18 LEGAL AND REGULATORY 51 RISK FACTORS 61 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 67 2 Management’s Discussion an |
|
| November 14, 2024 |
Exhibit 99.1 IM Cannabis Reports Third Quarter Financial Results IMC pairs a +12% increase in revenue with a -16% decrease in the total operating expenses, building a solid foundation to deliver in 2025. TORONTO, and GLIL YAM, Israel, November 14, 2024 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its fina |
|
| November 14, 2024 |
IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of September 30, 2024 Exhibit 99.2 IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of September 30, 2024 (Unaudited) INDEX Page Interim Condensed Consolidated Statements of Financial Position 2 - 3 Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income 4 - 5 Interim Condensed Consolidated Statements of Changes in Equity 6 Interim Condensed Consolidated Statem |
|
| November 14, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended September 30, 2024. 2. No misrepresentations: Based on my kno |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION 6-K 1 zk2432281.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| November 6, 2024 |
IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET Exhibit 99.1 IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET TORONTO and GLIL YAM, Israel, November 6, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third 2024 ended Sep |
|
| November 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| November 5, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 10/31/2024: 2,232,359 Common Shares Date: November 5, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. |
|
| October 4, 2024 |
DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Exhibit 99.1 THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management Toronto, Ontario and Glil Yam, Israel – October 4, 2024 – IM Cannabis Corp. (“IM Cannabis” or the “Company”) (NASDAQ: IMCC) (CSE: |
|
| October 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| October 2, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 9/30/2024: 2,232,359 Common Shares Date: October 2, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Wh |
|
| October 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exe |
|
| October 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal e |
|
| October 2, 2024 |
IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2 Exhibit 99.1 IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2 TORONTO, GLIL YAM, Israel – October 2, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that the preliminary sales results in Germany by its German su |
|
| September 19, 2024 |
IM CANNABIS CORP. INCENTIVE COMPENSATION RECOVERY POLICY Exhibit 97 IM CANNABIS CORP. INCENTIVE COMPENSATION RECOVERY POLICY 1. Introduction. The Board of Directors of IM Cannabis Corp. (the “Company”) believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company's compensation philosophy. The Board has therefore adopted this pol |
|
| September 19, 2024 |
CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 12.1 CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 I, Oren Shuster, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements m |
|
| September 19, 2024 |
CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 12.2 CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 I, Uri Birenberg, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements |
|
| September 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 1) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC |
|
| September 11, 2024 |
IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors Exhibit 99.1 IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors TORONTO and GLIL YAM, Israel, September 11, 2024 - IM Cannabis Corp. (“IMC” or the “Company”) (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Mr. Shmulik Arbel has been appointed to the Company’s board of directors (the “Board”) eff |
|
| September 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal e |
|
| September 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| September 9, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 8/31/2024: 2,232,359 Common Shares Date: September 9, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. |
|
| August 14, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Uri Birenberg, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended June 30, 2024. 2. No misrepresentations: Based on my knowled |
|
| August 14, 2024 |
Exhibit 99.1 IM Cannabis Reports Second Quarter Financial Results IMC Germany delivers +200% in sales in first three months after German legalization, while overall revenue grows 12% vs Q2 2023 TORONTO, and GLIL YAM, Israel, August 14, 2024 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial result |
|
| August 14, 2024 |
Exhibit 99.2 IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of June 30, 2024 Canadian dollars in thousands (Unaudited) INDEX Page Interim Condensed Consolidated Statements of Financial Position F-2 - F-3 Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income F-4 - F-5 Interim Condensed Consolidated Statements of Changes in Equity F-6 In |
|
| August 14, 2024 |
Exhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 6 GEOGRAPHIES AND NEW MARKETS 6 BRANDS 8 NEW PRODUCT OFFERINGS 12 HIGH-QUALITY, RELIABLE SUPPLY 12 CORPORATE HIGHLIGHTS AND EVENTS 12 REVIEW OF FINANCIAL PERFORMANCE 18 LEGAL AND REGULATORY 46 RISK FACTORS 55 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 61 2 Management’s Discussion an |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| August 14, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended June 30, 2024. 2. No misrepresentations: Based on my knowle |
|
| August 6, 2024 |
6-K 1 zk2431771.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Add |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal exec |
|
| August 6, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 7/31/2024: 2,232,359 Common Shares Date: August 6, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Whe |
|
| August 6, 2024 |
IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14 Exhibit 99.1 IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET TORONTO and GLIL YAM, Israel, August 6, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter 2024 en |
|
| July 29, 2024 |
Exhibit 99.1 IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement TORONTO and GLIL YAM, Israel, July 29, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced that on July 26, 2024, it has received formal notic |
|
| July 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| July 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| July 12, 2024 |
IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis Exhibit 99.1 IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis TORONTO and GLIL YAM, Israel, July 12, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IM Cannabis”), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further to its press release dated July 5, 2024, effective today the Company’s common shares |
|
| July 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| July 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| July 5, 2024 |
IM Cannabis Announces Intention to Complete Consolidation Exhibit 99.1 IM Cannabis Announces Intention to Complete Consolidation TORONTO and GLIL YAM, Israel, July 5, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company”, “IM Cannabis”, or “IMC”), a leading medical cannabis company with operations in Israel and Germany, announces that the board of directors of the Company (the “Board”) has approved a consolidation of its issued and outs |
|
| July 5, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 6/30/2024: 13,394,136 Common Shares Date: July 5, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Wher |
|
| June 6, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC” or the "Company") Trading Symbol: IMCC Number of Outstanding Listed Securities as of 5/31/2024: 13,394,136 Common Shares Date: June 6, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Wher |
|
| June 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| June 5, 2024 |
Exhibit 99.1 IMCC Addresses Accelerated Growth in Germany Through new Supply Agreement with EU-GMP Certified Glasshouse Botanics and Announces a Change to its Board of Directors IMC Germany’s accelerated growth potential leans strongly on its supply strategy through its ability to partner with cannabis growers for EU-GMP certification, bolstering the company’s supply chain with exclusive product. |
|
| June 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| May 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 29, 2024 |
IM Cannabis Closes Convertible Debenture Offering to Support Accelerated Growth in Germany Exhibit 99.1 IM Cannabis Closes Convertible Debenture Offering to Support Accelerated Growth in Germany Through continuous, active cost management, IMC reduced its annual G&A costs by 49% in 2023 and is now looking to significantly reduce its financial costs. TORONTO and GLIL YAM, Israel, May 29, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company”, “IM Cannabis”, or “IMC”), a l |
|
| May 8, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.4 Form 52-109F2 Certification of Interim Filings Full Certificate I, Uri Birenberg, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended March 31, 2024. 2. No misrepresentations: Based on my knowle |
|
| May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 8, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Exhibit 99.5 Form 52-109F2 Certification of Interim Filings Full Certificate I, Oren Shuster, the Chief Executive Officer of IM Cannabis Corp., certify the following: 1. Review: : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of IM Cannabis Corp. (the “issuer”) for the interim period ended March 31, 2024. 2. No misrepresentations: Based on my knowl |
|
| May 8, 2024 |
Exhibit 99.1 IM Cannabis Reports First Quarter Financial Results IMC prepares for accelerated growth after legalization in Germany and recovers from the impact of the Israel-Hamas war. TORONTO, and GLIL YAM, Israel, May 8, 2024 /PRNewswire/ - IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for t |
|
| May 8, 2024 |
Exhibit 99.3 Management’s Discussion and Analysis TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 6 GEOGRAPHIES AND NEW MARKETS 6 BRANDS 8 NEW PRODUCT OFFERINGS 12 HIGH-QUALITY, RELIABLE SUPPLY 12 CORPORATE HIGHLIGHTS AND EVENTS 13 REVIEW OF FINANCIAL PERFORMANCE 18 LEGAL AND REGULATORY 44 RISK FACTORS 53 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 59 2 Management’s Discussion an |
|
| May 8, 2024 |
Exhibit 99.2 IM CANNABIS CORP. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of March 31, 2024 Canadian dollars in thousands (Unaudited) INDEX Page Interim Condensed Consolidated Statements of Financial Position 2 - 3 Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income 4 - 5 Interim Condensed Consolidated Statements of Changes in Equity 6 Interim Con |
|
| May 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| May 6, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 4/30/2024: 13,394,136 Common Shares Date: May 6, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was i |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executi |
|
| May 1, 2024 |
IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8 Exhibit 99.1 IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9:00am ET TORONTO and GLIL YAM, Israel, May 1, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2024 ended March |
|
| April 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| April 16, 2024 |
IMC to transfer its Oranim Pharmacy shares back to the seller Exhibit 99.1 IMC to transfer its Oranim Pharmacy shares back to the seller TORONTO and GLIL YAM, Israel, April 16, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installmen |
|
| April 9, 2024 |
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market Exhibit 99.1 IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market TORONTO and GLIL YAM, Israel, April 9, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, entered, through its subsidiary, a strategic distribution agreement with Vessel |
|
| April 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| April 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| April 4, 2024 |
Avant and IMC Execute BLK MKTTM Trademark Licensing Agreement for the German Medical Cannabis Market Exhibit 99.1 Avant and IMC Execute BLK MKTTM Trademark Licensing Agreement for the German Medical Cannabis Market TORONTO, GLIL YAM, Israel and KELOWNA B.C. - April 4, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, and Avant Brands Inc. (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BU0) |
|
| April 4, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 3/31/2024: 13,394,136 Common Shares Date: April 4, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was |
|
| April 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execut |
|
| April 1, 2024 |
Exhibit 99.1 IMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients. With the implementation of the anticipated medical cannabis regulatory reform, the Israeli ministry of health removed many of the heavy regulations in the sector, making medical cannabis more accessible to new patients. TORONTO and GLIL YAM, Israel, April 1, 202 |
|
| March 28, 2024 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of IM Cannabis Corp. (the "Company") on Form 20-F for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Oren Shuster, Chief Executive Officer of the Company, cert |
|
| March 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT |
|
| March 28, 2024 |
CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 12.2 CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 I, Uri Birenberg, certify that: 1. I have reviewed this annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the c |
|
| March 28, 2024 |
Consent of Independent Registered Public Accounting Firm EXHIBIT 15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement (Form F-10 No. 333-254255) of IM Cannabis Corp. and in the related Prospectus of our report dated March 28, 2024, with respect to the consolidated financial statements of IM Cannabis Corp. included in this Annual Report (Form 20-F) for the year ended Dece |
|
| March 28, 2024 |
IM CANNABIS CORP. STOCK TRADING POLICY Exhibit 11.1 IM CANNABIS CORP. STOCK TRADING POLICY IM CANNABIS CORP. STOCK TRADING POLICY 1. Purpose of this Policy The board of directors (the “Board”) of IM Cannabis Corp. (the “Company”) has adopted this Stock Trading Policy (the “Policy”), which is designed to provide guidance to the directors, officers and employees of the Company and its subsidiaries (who are referred to collectively in thi |
|
| March 28, 2024 |
CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 Exhibit 12.1 CERTIFICATION REQUIRED BY RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 I, Oren Shuster, certify that: 1. I have reviewed this annual report on Form 20-F of IM Cannabis Corp. (the "Issuer"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the ci |
|
| March 28, 2024 |
Exhibit 4.5 LOAN AGREEMENT THIS LOAN AGREEMENT (this “Loan Agreement”, or the “Agreement”) is made and entered this February 28, 2024 (the “Effective Date”), by and between I.M.C Holdings Ltd., an Israeli limited liability company, of Beit HaKshatot, Glil Yam, Israel 4690500 (the “Company” or “Borrower”) and Kadimastem Ltd., an Israeli limited liability company, of Pinchas Sapir 7, Weizmann Scienc |
|
| March 28, 2024 |
Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of IM Cannabis Corp. (the "Company") on Form 20-F for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Uri Birenberg, Chief Financial Officer of the Company, cer |
|
| March 28, 2024 |
Exhibit 15.2 TABLE OF CONTENTS EXECUTIVE SUMMARY 4 STRATEGY IN DETAIL 6 GEOGRAPHIES AND NEW MARKETS 6 BRANDS 8 NEW PRODUCT OFFERINGS 12 HIGH-QUALITY, RELIABLE SUPPLY 13 CORPORATE HIGHLIGHTS AND EVENTS 13 REVIEW OF FINANCIAL PERFORMANCE 25 LEGAL AND REGULATORY 54 RISK FACTORS 62 CAUTION CONCERNING FORWARD-LOOKING INFORMATION 67 2 INTRODUCTION IM Cannabis Corp. (“IM Cannabis” or the “Company”) is a |
|
| March 25, 2024 |
IMC Welcomes the Groundbreaking Cannabis Legalization in Germany Exhibit 99.1 IMC Welcomes the Groundbreaking Cannabis Legalization in Germany By rescheduling medical cannabis, from a narcotic to a regular prescription, the German medical cannabis market is expected to deliver strong growth, providing IMC Germany with a unique opportunity to further accelerate growth in 2024 after delivering 180% growth in 2023. TORONTO and GLIL YAM, Israel, March 25, 2024/CNW/ |
|
| March 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| March 20, 2024 |
Exhibit 99.1 IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ET TORONTO and GLIL YAM, Israel, March 20, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth quart |
|
| March 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| March 6, 2024 |
Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. (the “Issuer” or “IMC”) Trading Symbol: IMCC Number of Outstanding Listed Securities as of 2/29/2024: 13,394,136 Common Shares Date: March 6, 2024 Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was |
|
| March 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal execu |
|
| February 28, 2024 |
Exhibit 99.1 Not for distribution to United States newswire services or for dissemination in the United States IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company. TORONTO and GLIL YAM, Israel, February 28, 2024/CNW/ - IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Ge |
|
| February 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
|
| February 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024. Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal ex |
